XML 22 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net income $ 38,332,000 $ 48,862,000 $ 39,526,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,893,000 8,213,000 6,477,000
Net amortization of premiums on securities 3,474,000 2,069,000 2,456,000
Provision for credit losses 27,184,000 8,044,000 8,934,000
Share-based compensation 1,333,000 1,406,000 1,301,000
Deferred income tax (benefit) expense (4,523,000) 369,000 (10,480,000)
Proceeds from sale of loans held for sale 97,238,000 41,479,000 30,547,000
Originations of loans held for sale (93,461,000) (41,626,000) (29,901,000)
Income on company owned life insurance (1,902,000) (1,758,000) (1,793,000)
Net gain on sale of loans held for sale (3,858,000) (1,352,000) (796,000)
Net (gain) loss on investment securities (1,599,000) (1,677,000) 127,000
Goodwill impairment   0 2,350,000
Net loss (gain) on other assets 61,000 (29,000) (50,000)
Noncash restructuring charges against assets 202,000    
(Increase) decrease in other assets (37,565,000) (21,263,000) 13,376,000
Increase in other liabilities 10,646,000 14,973,000 3,065,000
Net cash provided by operating activities 43,455,000 57,710,000 65,139,000
Cash flows from investing activities:      
Purchases of available for sale securities (396,879,000) (195,660,000) (44,919,000)
Purchases of held to maturity securities (7,345,000) (23,494,000) (28,017,000)
Proceeds from principal payments, maturities and calls on available for sale securities 97,685,000 82,358,000 90,114,000
Proceeds from principal payments, maturities and calls on held to maturity securities 93,046,000 83,508,000 96,211,000
Proceeds from sales of securities available for sale 107,098,000 178,059,000 29,851,000
Proceeds from sales of securities held to maturity 52,000    
Net loan originations (390,932,000) (167,234,000) (361,915,000)
Loans sold to others   21,077,000  
Purchases of company owned life insurance, net of proceeds received (30,051,000) (68,000) (35,000)
Proceeds from sales of other assets 519,000 360,000 590,000
Purchases of premises and equipment (4,264,000) (3,639,000) (2,842,000)
Cash consideration paid for acquisition, net of cash acquired     (4,447,000)
Net cash used in investing activities (531,071,000) (24,733,000) (225,409,000)
Cash flows from financing activities:      
Net increase in deposits 722,692,000 188,768,000 156,733,000
Net increase in short-term borrowings (270,200,000) (194,000,000) 23,300,000
Repurchase of preferred stock     (1,000)
Issuance of long-term debt 35,000,000    
Debt issuance costs (779,000)    
Purchases of common stock for treasury (209,000) (293,000) (113,000)
Proceeds from stock options exercised     320,000
Cash dividends paid to preferred shareholders (1,461,000) (1,461,000) (1,462,000)
Cash dividends paid to common shareholders (16,496,000) (15,799,000) (14,947,000)
Net cash provided by (used in) financing activities 468,547,000 (22,785,000) 163,830,000
Net (decrease) increase in cash and cash equivalents (19,069,000) 10,192,000 3,560,000
Cash and cash equivalents, beginning of period 112,947,000 102,755,000 99,195,000
Cash and cash equivalents, end of period $ 93,878,000 $ 112,947,000 $ 102,755,000